Emerging therapeutic paradigms in tuberculosis: Nanocarriers, host-directed strategies, and translational pharmacology
Microbial Pathogenesis · 2026
DOI: 10.1016/j.micpath.2026.108545 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2026. Verfasst von Anjali Saxena und 4 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Tuberculosis, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 241 Literaturangaben. Gefördert von: Alexander von Humboldt Foundation, Amity Institute of Biotechnology, Amity University, Amity University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India.
- Department of Industrial Biotechnology, College of Biotechnology, CCS Haryana Agricultural University, Hisar, (Haryana), India.
- Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India. Electronic address: biswasaha@gmail.com.
Förderung
- Alexander von Humboldt Foundation
- Amity Institute of Biotechnology, Amity University
- Amity University
Zitieren
APA
Saxena, A., Bhagra, S., Das, S., Kaushik, N., & Saha, B. (2026). Emerging therapeutic paradigms in tuberculosis: Nanocarriers, host-directed strategies, and translational pharmacology. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2026.108545
Vancouver
Saxena A, Bhagra S, Das S, Kaushik N, Saha B. Emerging therapeutic paradigms in tuberculosis: Nanocarriers, host-directed strategies, and translational pharmacology. Microbial Pathogenesis. 2026. doi:10.1016/j.micpath.2026.108545
BibTeX
@article{Saxena2026,
author = {Saxena, Anjali and Bhagra, Summer and Das, Shuvayoo and Kaushik, Naveen and Saha, Biswajit},
title = {Emerging therapeutic paradigms in tuberculosis: Nanocarriers, host-directed strategies, and translational pharmacology},
journal = {Microbial Pathogenesis},
year = {2026},
doi = {10.1016/j.micpath.2026.108545}
}
EUVIMED